BBIBP-CorV

BBIBP-CorV
Data klinis
Rute
pemberian
Intraotot
Status hukum
Status hukum

BBIBP-CorV adalah salah satu dari dua vaksin COVID-19 virus inaktivasi yang dikembangkan oleh Sinopharm. Pada Desember 2020, vaksin tersebut berada dalam pengujian Tahap III di Argentina, Bahrain, Mesir, Maroko, Pakistan, Peru, dan Uni Emirat Arab dengan lebih dari 60.000 partisipan.[1] Pada November, sekitar satu juta orang mendapatkan vaksin tersebut melalui program pemakaian darurat Tiongkok.[1]

Lihat pula

Referensi

  1. ^ a b Staff, Reuters (2020-11-19). "China Sinopharm's coronavirus vaccine taken by about a million people in emergency use". Reuters (dalam bahasa Inggris). Diakses tanggal 2020-12-09.



Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.